Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

No products in the cart.

HUMALOG™ MIX 50 suspension for subcutaneous injection 100IU/ml (3ml), 5 cartridges with QuickPen

🔥 9 items sold in last 3 hours
21 people are viewing this product
Active Ingredient:

Manufacturer:

$121.00

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

ABAKTAL™ tablets 400mg, 10pcs

$42.00
Add to cart

ABISIL™ oily solution 20% (15ml), 1pc

$54.00
Add to cart

Analogs of HUMALOG™ MIX 50

RINLIZ™ MIX 25 suspension for subcutaneous injection 100IU/ml (3ml), cartridges in RINASTRA II pen injector, 5pcs

$121.00
Add to cart

Table of Contents

HUMALOG™ MIX 50 100IU Suspension 3ml Buy Online

Understanding Humalog Mix 50

Humalog Mix 50 is a crucial medication for managing diabetes, offering a convenient blend of fast-acting and intermediate-acting insulin. Its unique formulation allows for precise blood sugar control, making it a valuable tool in a comprehensive diabetes management plan. This insulin combination simplifies the daily routine for many patients needing insulin therapy.

This premixed insulin combines the speed of lispro insulin (a fast-acting analog) with the sustained action of protamine-suspended lispro insulin (an intermediate-acting analog). This dual action helps manage both immediate and long-term blood glucose levels. Careful monitoring and physician guidance are essential for optimal results.

The precise ratio of 50/50 (fast-acting to intermediate-acting) in Humalog Mix 50 provides a balanced approach to glucose regulation. This balance aims to cover both immediate post-meal glucose spikes and provide sustained control throughout the day. Individual dosage adjustments are critical based on patient-specific needs and glucose monitoring.

A Fast-Acting Insulin Solution

Humalog Mix 50 is designed to provide a rapid and reliable response to rising blood glucose levels. The inclusion of lispro insulin ensures a prompt onset of action, typically within 15 minutes of subcutaneous injection. This rapid action is particularly beneficial for managing blood sugar spikes that often occur after meals.

Unlike some slower-acting insulins, Humalog Mix 50’s fast-acting component allows for more precise timing of insulin administration relative to food intake. This characteristic makes it a practical choice for individuals who need to closely match their insulin doses with meal consumption. The quick onset makes it suitable for managing hyperglycemia quickly and effectively.

This rapid action is a key advantage for managing the postprandial (after-meal) rise in blood glucose. The fast-acting insulin component works quickly to prevent excessively high blood sugar levels, contributing to better overall glucose control. The speed of action is a significant factor in minimizing fluctuations in blood glucose.

However, it’s crucial to remember that the fast-acting nature of Humalog Mix 50 necessitates careful monitoring and precise timing of injections. A misunderstanding of the rapid onset could lead to hypoglycemia (low blood sugar). Therefore, close collaboration with a healthcare professional to establish the appropriate dosage and timing is essential.

The convenience of a pre-mixed formulation further enhances its practicality. The pre-mixed nature eliminates the need for separate mixing of fast-acting and intermediate-acting insulins, thus simplifying the administration process. This pre-mixed design reduces the preparation time and potential for error, ensuring consistent dosage administration.

Composition and Mechanism of Action

Humalog Mix 50 is a biphasic insulin formulation, meaning it contains two types of insulin lispro: a rapid-acting solution and an intermediate-acting suspension. This unique blend allows for a combination of immediate and prolonged glucose control. The precise 50/50 ratio ensures a balanced approach to managing blood sugar levels throughout the day.

The rapid-acting lispro insulin component works quickly to address immediate post-meal glucose spikes. This component starts working within minutes of injection, effectively lowering blood glucose levels that rise after eating. Its swift action makes it ideal for managing the immediate impact of carbohydrate intake.

Conversely, the intermediate-acting protamine-suspended lispro insulin provides a more sustained action, offering longer-lasting glucose control between meals and overnight. This component ensures a more stable blood glucose level, preventing dramatic drops or rises throughout the day and into the night. This sustained action is crucial for preventing hypoglycemia during periods of fasting.

The mechanism of action hinges on the ability of insulin lispro to bind to insulin receptors on cells throughout the body. Upon binding, the insulin facilitates the uptake of glucose from the bloodstream into cells, where it is used for energy production. This process lowers blood glucose levels, helping to maintain glucose homeostasis.

The combined effect of the rapid and intermediate components in Humalog Mix 50 offers a more comprehensive approach to blood sugar management compared to single-action insulin preparations. This combined action minimizes fluctuations and helps maintain blood glucose within a more desirable range. The balanced action is designed to simplify the insulin regimen for many individuals with diabetes.

It is important to understand that the precise duration and intensity of action may vary depending on factors such as the injection site, individual metabolism, and the amount of insulin administered. Regular monitoring of blood glucose levels is critical to optimize the effectiveness of Humalog Mix 50 and ensure safe and effective glucose control.

Dosage and Administration

Humalog Mix 50 is administered subcutaneously, meaning the injection is given under the skin. Common injection sites include the abdomen, thigh, upper arm, and buttocks. Rotating injection sites helps to prevent lipohypertrophy (thickening of the skin at the injection site) and improves insulin absorption.

The dosage of Humalog Mix 50 is strictly individualized and determined by a healthcare professional based on factors such as blood glucose levels, dietary intake, physical activity, and overall health status. Regular monitoring of blood glucose is essential for appropriate dosage adjustments. Never adjust your dosage without consulting your doctor.

Typically, Humalog Mix 50 is injected 0-15 minutes before a meal to help manage the postprandial rise in blood glucose. This timing is crucial for the effectiveness of the rapid-acting insulin component. Precise timing is essential to avoid both hyperglycemia (high blood sugar) and hypoglycemia (low blood sugar).

Before administering the injection, the cartridge should be gently rolled between the palms to ensure a uniform suspension. This step is vital for accurate and consistent insulin delivery. Failure to properly mix the solution may result in inconsistent blood sugar control.

The use of the provided QuickPen device simplifies the injection process. The QuickPen allows for precise and consistent insulin delivery, minimizing the risk of errors in dosage. Always follow the instructions provided with the QuickPen to ensure proper usage.

It’s crucial to emphasize that self-administering Humalog Mix 50 requires proper training and understanding of the medication and its administration. Patients should receive thorough instruction from their healthcare provider on proper injection techniques, dosage adjustments, and potential side effects. Ongoing monitoring and close communication with your doctor are essential for safe and effective management of your diabetes.

Benefits of Using Humalog Mix 50

Humalog Mix 50 offers several key advantages for individuals managing diabetes. Its biphasic nature provides both rapid and sustained glucose control, addressing both immediate post-meal spikes and longer-term blood sugar regulation. This dual action simplifies the insulin regimen, reducing the need for multiple injections.

The rapid onset of action of the lispro insulin component allows for precise timing of insulin administration relative to meals. This precise timing allows for better control over postprandial blood glucose excursions, reducing the risk of hyperglycemia. This characteristic is particularly beneficial for managing blood sugar spikes after carbohydrate-rich meals.

The convenience of a pre-mixed formulation simplifies insulin administration. Eliminating the need for mixing separate insulin components reduces the risk of errors and streamlines the injection process. This pre-mixed format simplifies the daily routine for those using insulin therapy.

The availability of the QuickPen delivery system further enhances the ease of use. The QuickPen provides a user-friendly and accurate method of administering the insulin, increasing patient compliance and reducing the chance of injection errors. This system is designed for convenience and precision in insulin delivery.

Furthermore, the balanced action of Humalog Mix 50 contributes to better overall glycemic control, potentially minimizing the risk of long-term complications associated with poorly managed diabetes. This improved control can lead to better overall health and well-being for individuals with diabetes. Consistent glucose control is essential for preventing or delaying the onset of diabetic complications.

However, it is crucial to remember that individual responses to Humalog Mix 50 can vary. Close monitoring of blood glucose levels and regular communication with a healthcare professional are essential for optimizing treatment and ensuring safe and effective glucose management. Individualized treatment plans are crucial for optimal outcomes.

Pros

  • Convenient Pre-mixed Formulation: Humalog Mix 50 simplifies insulin administration by eliminating the need to mix separate rapid-acting and intermediate-acting insulins. This pre-mixed design streamlines the process, saving time and reducing the potential for errors.
  • Rapid Onset of Action: The inclusion of lispro insulin ensures a swift onset of action, typically within 15 minutes. This rapid effect is crucial for managing postprandial (after-meal) blood glucose spikes effectively.
  • Balanced Glucose Control: The 50/50 blend of rapid-acting and intermediate-acting insulins provides both immediate and sustained glucose control, helping to maintain stable blood sugar levels throughout the day and night. This balanced approach minimizes extreme fluctuations.
  • User-Friendly Delivery System: The QuickPen device simplifies injection, increasing patient compliance and reducing the risk of inaccurate dosing. Its design enhances precision and ease of use, improving the overall experience.
  • Improved Glycemic Control: By effectively managing both immediate and prolonged blood glucose levels, Humalog Mix 50 contributes to better overall glycemic control, potentially minimizing the risk of long-term diabetic complications. This improved control can enhance overall health outcomes.

These advantages contribute to a more manageable and effective diabetes management plan, improving patient quality of life and potentially reducing the risk of long-term complications.

Potential Drawbacks of Humalog Mix 50

While Humalog Mix 50 offers significant benefits, it’s essential to acknowledge potential drawbacks. The rapid onset of action, while advantageous for managing post-meal glucose spikes, also necessitates precise timing of injections. Inaccurate timing can lead to episodes of hypoglycemia (low blood sugar), requiring careful attention to meal timing and insulin administration.

Individual responses to insulin can vary significantly. What works well for one person may not be as effective for another, necessitating careful monitoring and potential adjustments in dosage. Factors such as diet, exercise, and overall health can influence the effectiveness of Humalog Mix 50. Regular blood glucose monitoring is therefore crucial.

As with all insulin therapies, hypoglycemia remains a potential risk. Symptoms can range from mild (trembling, sweating) to severe (loss of consciousness), necessitating prompt treatment with glucose. Patients should be educated on recognizing and managing hypoglycemic episodes. Carrying a readily available source of glucose is also recommended.

The need for regular blood glucose monitoring is a significant consideration. Effective management with Humalog Mix 50 relies heavily on consistent monitoring to adjust dosages and ensure blood glucose levels remain within the target range. Frequent blood glucose testing is essential for safe and effective use.

Finally, injection site reactions, such as redness, swelling, or itching, can occur. Rotating injection sites can help minimize these reactions. However, if reactions persist or worsen, it’s important to seek medical attention. Proper injection techniques are also critical to minimize discomfort and complications at the injection site.

These potential drawbacks underscore the importance of close collaboration with a healthcare professional to establish an appropriate treatment plan, monitor effectiveness, and address any adverse effects promptly. Regular communication and monitoring are crucial for optimizing treatment and ensuring patient safety.

Cons

  • Risk of Hypoglycemia: The rapid-acting component of Humalog Mix 50 necessitates precise timing of injections relative to meals. Inaccurate timing or insufficient carbohydrate intake can lead to hypoglycemia (low blood sugar), a potentially dangerous condition requiring prompt treatment.
  • Individual Variability in Response: The effectiveness of Humalog Mix 50 can vary significantly between individuals. Factors such as diet, exercise, and overall health can influence insulin requirements, necessitating close monitoring and potential dosage adjustments.
  • Need for Frequent Blood Glucose Monitoring: Effective management with Humalog Mix 50 requires regular blood glucose monitoring to ensure blood sugar levels remain within the target range and to make necessary dosage adjustments. This frequent monitoring is essential for safe and effective use.
  • Potential for Injection Site Reactions: Like other injectable medications, Humalog Mix 50 can cause injection site reactions such as redness, swelling, or itching. Rotating injection sites can help minimize these reactions, but they can still occur.
  • Requires Medical Supervision: Humalog Mix 50 is a prescription medication requiring close collaboration with a healthcare professional for appropriate dosage determination, monitoring, and management of potential side effects. Self-management requires proper training and ongoing medical guidance.

These potential drawbacks highlight the importance of careful monitoring, adherence to prescribed dosages, and regular communication with a healthcare provider for safe and effective use of Humalog Mix 50.

Important Considerations

Before initiating treatment with Humalog Mix 50, a comprehensive assessment of your individual needs is crucial. This assessment should include a thorough review of your medical history, current medications, and lifestyle factors. Your doctor will work with you to determine the appropriate starting dose and refine the regimen as needed based on your responses.

Regular blood glucose monitoring is paramount for successful management with Humalog Mix 50. Frequent testing provides valuable insights into how your body responds to the medication and allows for timely adjustments to optimize blood sugar control. This monitoring is essential for preventing both hyperglycemia and hypoglycemia.

Dietary consistency plays a significant role in managing blood glucose levels. Working with a registered dietitian or nutritionist can help you develop a meal plan that complements your insulin regimen. A well-planned diet, in conjunction with Humalog Mix 50, contributes to better overall glycemic control.

Physical activity also significantly impacts blood sugar levels. Regular exercise enhances insulin sensitivity, improving glucose control. However, the intensity and timing of exercise may need to be adjusted to avoid hypoglycemia. Consult your healthcare provider for personalized exercise recommendations.

It’s crucial to be aware of the potential for drug interactions. Certain medications can affect insulin metabolism and may require adjustments to your Humalog Mix 50 dosage. Always inform your doctor about all medications, including over-the-counter drugs and supplements, you are taking. Open communication with your physician is key to avoiding potential complications.

Finally, understanding the signs and symptoms of hypoglycemia is crucial. Prompt recognition and treatment of hypoglycemic episodes are essential to prevent severe consequences. Learn to identify symptoms and keep a readily available source of fast-acting glucose on hand. Education and preparedness are crucial aspects of safe and effective diabetes management.

  • Humalog™ Mix 50 Suspension For Subcutaneous Injection 100Iu/Ml (3Ml), 5 Cartridges With Quickpen Buy Online 2
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Humalog™ Mix 50 Suspension For Subcutaneous Injection 100Iu/Ml (3Ml), 5 Cartridges With Quickpen Buy Online 4
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Humalog™ Mix 50 Suspension For Subcutaneous Injection 100Iu/Ml (3Ml), 5 Cartridges With Quickpen Buy Online 6
    [Medical reviewer]

    Dr. Lewis Rappaport is a highly experienced and respected cardiologist who serves as a salaried specialist and consultant for the licensed online pharmacy, RxPulsar.com. With over 30 years of practice...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “HUMALOG™ MIX 50 suspension for subcutaneous injection 100IU/ml (3ml), 5 cartridges with QuickPen”

Your email address will not be published. Required fields are marked

Similar products

RINSULIN™ R solution for injection 100IU/ml (10ml), vial 1pc

$33.00
Add to cart

NOVOMIX™ 30 FLEXPEN suspension for subcutaneous injection 100U/ml (3ml), cartridges in pen injectors 5pcs

$135.00
Add to cart

NOVORAPID™ FLEXPEN solution for injection 100U/ml (3ml), cartridges in pre-filled pens 5pcs

$127.00
Add to cart

BIOSULIN™ R solution for injection 100IU/ml (10ml), vial 1pc

$38.00
Add to cart

BIOSULIN™ R solution for injection 100IU/ml (3ml), cartridges 5pcs

$69.00
Add to cart

BIOSULIN™ R solution for injection 100IU/ml (3ml), cartridges in BIOMATICPEN pens 5pcs

$102.00
Add to cart

ACTRAPID™ HM injection solution 100IU/ml (10ml), vial 1pc

$31.00
Add to cart
Select your currency